Bionik Laboratories Corp (BNKL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 372 | 18 | 164 | 0 | 0 |
| Cost of Goods | 335 | 12 | 59 | N/A | N/A |
| Gross Profit | 38 | 6 | 105 | N/A | N/A |
| Operating Expenses | 1,954 | 1,419 | 2,096 | 1,936 | 0 |
| Operating Income | -1,582 | -1,401 | -1,932 | -1,936 | N/A |
| Interest Expense | 14 | -5 | 15 | -7 | 0 |
| Other Income | 14 | -5 | -376 | 935 | 0 |
| Pre-tax Income | -1,582 | -1,401 | -2,323 | -994 | 0 |
| Net Income Continuous | -1,582 | -1,401 | -2,323 | -994 | N/A |
| Net Income | $-1,582 | $-1,401 | $-2,323 | $-994 | $N/A |
| EPS Basic Total Ops | -2.99 | -2.99 | -4.48 | -2.99 | N/A |
| EPS Basic Continuous Ops | -2.45 | -2.43 | -4.23 | -1.86 | N/A |
| EPS Diluted Total Ops | -2.99 | -2.99 | -4.48 | -8.96 | N/A |
| EPS Diluted Continuous Ops | -2.45 | -2.43 | -4.23 | -1.84 | N/A |
| EBITDA(a) | $-1,544 | $-1,382 | $-1,906 | $-1,933 | $N/A |